Target Price | DKK877.57 |
Price | DKK729.40 |
Potential |
20.31%
register free of charge
|
Number of Estimates | 23 |
23 Analysts have issued a price target Coloplast A/S B 2026 .
The average Coloplast A/S B target price is DKK877.57.
This is
20.31%
register free of charge
DKK1,050.00
43.95%
register free of charge
DKK694.00
4.85%
register free of charge
|
|
A rating was issued by 26 analysts: 12 Analysts recommend Coloplast A/S B to buy, 12 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2026 of
20.31%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion DKK | 27.03 | 28.90 |
10.33% | 6.90% | |
EBITDA Margin | 32.19% | 32.46% |
0.35% | 0.85% | |
Net Margin | 18.73% | 15.44% |
8.34% | 17.55% |
23 Analysts have issued a sales forecast Coloplast A/S B 2025 . The average Coloplast A/S B sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Coloplast A/S B EBITDA forecast 2025. The average Coloplast A/S B EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Coloplast A/S B Analysts have issued a net profit forecast 2025. The average Coloplast A/S B net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share DKK | 22.46 | 19.80 |
1.13% | 11.84% | |
P/E | 36.85 | |
EV/Sales | 6.34 |
18 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B EPS is
This results in the following potential growth metrics and future valuations:
Coloplast A/S B...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
REDBURN ATLANTIC |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
EQUITA SIM |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
DNB MARKETS |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
Locked
REDBURN ATLANTIC:
Locked
➜
Locked
|
Mar 20 2025 |
Locked
EQUITA SIM:
Locked
➜
Locked
|
Feb 06 2025 |
Locked
DNB MARKETS:
Locked
➜
Locked
|
Feb 04 2025 |
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Feb 04 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.